WHO-GMP Certified
International quality standards
Vivifi Life Sciences Pvt Ltd is dedicated to improving the quality of life by reducing the burden of disease through innovative pharmaceutical solutions and WHO-GMP certified manufacturing excellence.
TOPVOG - 0.3 Tablets
Description
Topvog 0.3 mg contains Voglibose, which works in the intestine to delay the digestion and absorption of carbohydrates. By slowing glucose entry into the bloodstream after meals, it helps reduce sudden spikes in blood sugar levels.
It is commonly prescribed when:
- Diet and lifestyle measures are insufficient
- Other oral antidiabetic medicines do not adequately control post-meal glucose levels
- Additional glycemic regulation is required
Proper postprandial glucose control plays a key role in preventing long-term complications such as:
- Diabetic nephropathy
- Diabetic retinopathy
- Nerve damage (neuropathy)
- Cardiovascular complications
How It Works
Voglibose acts locally within the gastrointestinal tract by:
- Inhibiting enzymes responsible for carbohydrate breakdown
- Slowing glucose absorption after meals
- Reducing sharp increases in blood sugar
Unlike insulin-stimulating medicines, it controls sugar levels without directly increasing insulin secretion.
Dosage & Administration
- Take just before meals
- Follow your doctor’s prescribed dose and schedule
- Take it consistently as directed
- Do not stop the medicine abruptly without medical advice
The exact dosage depends on your blood glucose levels and overall diabetes treatment plan.
Important Treatment Guidance
Discontinuing treatment without consulting your doctor may lead to uncontrolled blood sugar levels, increasing the risk of complications such as kidney damage, vision impairment, and nerve disorders.
Topvog works best when combined with:
- A balanced diabetic diet
- Regular physical activity
- Routine blood sugar monitoring
- Ongoing medical supervision
Long-term diabetes control requires consistent medication adherence and lifestyle management.
Quality Assurance
✔ WHO-GMP Certified Manufacturing
✔ International Quality Standards
✔ Strict Quality Control Protocols
✔ Batch-wise Safety & Efficacy Testing
Each batch undergoes comprehensive evaluation to ensure purity, potency, and reliability.
Manufacturer
Vivifi Pharma
Delivering high-quality pharmaceutical solutions across cardiovascular and chronic care segments.
Disclaimer:
This information is for educational purposes only and does not substitute professional medical advice. Always consult a qualified healthcare provider before starting or modifying any medication.
FAQ
1. What is Topvog 0.3 mg Tablet used for?
Topvog 0.3 mg Tablet helps control post-meal blood sugar spikes in adults with Type 2 diabetes, particularly when lower doses or other medicines are not sufficient.
2. How is Topvog 0.3 mg different from 0.2 mg?
Topvog 0.3 mg is a higher-strength formulation and may be prescribed when additional postprandial glucose control is required. The appropriate dose is decided by your doctor
3. What are the possible side effects of Topvog 0.3 mg?
Common side effects include gas, bloating, abdominal discomfort, and diarrhea due to delayed carbohydrate digestion. These are generally mild and may reduce over time.
4. Who should take Topvog 0.3 mg with caution?
Patients with digestive disorders, severe kidney or liver disease, or those on multiple diabetes medications should use it only under medical supervision. Always inform your doctor about your medical history.
Quality Assured
Rigorous testing protocols